cover image: Review - Diagnosis and management of eosinophilic esophagitis - Who gets eosinophilic esophagitis?

20.500.12592/q2bvwdv

Review - Diagnosis and management of eosinophilic esophagitis - Who gets eosinophilic esophagitis?

14 Feb 2024

doi: 10.1503/cmaj.230378 Eosinophilic esophagitis is a chronic condition, which can affect both children and adults and encompasses a spectrum of disor- Key points ders; it is a common cause of esophageal dysphagia, esophageal narrowing and food impaction.1–6 Given its increased recognition • Eosinophilic esophagitis is a chronic inflammatory disease of both children and adults, for which incidenc. [...] A detailed dietary history is essential to often diagnosed in the summer, further underscoring the role of decipher which types of foods a patient avoids and why.30 aeroallergen triggers.26,27 Patients with eosinophilic esophagitis may avoid meat and Adaptive eating behaviours and anxieties around meals are bread because of previous choking episodes, while patients with common. [...] Technical review on the management of (BSG) and British Society of Paediatric Gastroenterology, Hepatology and eosinophilic esophagitis: a report from the AGA Institute and the joint Task Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and manage- force on allergy-immunology practice parameters. [...] Pathophysiology of eosinophilic esoph- of the spectrum of eosinophilic oesophagitis. [...] Dupilumab safety and efficacy up Regeneron, AVIR Pharma, Bausch Health, Takeda and AstraZeneca, to 52weeks in adult and adolescent patients with eosinophilic esophagitis: and participates on advisory boards for AVIR Pharma and Sanofi results from part A and C of a randomized, placebo-controlled, three-part, Regeneron.
Pages
8
Published in
Canada